Improving Artificial Intelligence-Based Diagnosis on Pediatric Skin Lesions
- PMID: 36804150
- PMCID: PMC10431965
- DOI: 10.1016/j.jid.2022.08.058
Improving Artificial Intelligence-Based Diagnosis on Pediatric Skin Lesions
Abstract
Artificial intelligence algorithms to classify melanoma are dependent on their training data, which limits generalizability. The objective of this study was to compare the performance of an artificial intelligence model trained on a standard adult-predominant dermoscopic dataset before and after the addition of additional pediatric training images. The performances were compared using held-out adult and pediatric test sets of images. We trained two models: one (model A) on an adult-predominant dataset (37,662 images from the International Skin Imaging Collaboration) and the other (model A+P) on an additional 1,536 pediatric images. We compared performance between the two models on adult and pediatric held-out test images separately using the area under the receiver operating characteristic curve. We then used Gradient-weighted Class Activation Maps and background skin masking to understand the contributions of the lesion versus background skin to algorithm decision making. Adding images from a pediatric population with different epidemiological and visual patterns to current reference standard datasets improved algorithm performance on pediatric images without diminishing performance on adult images. This suggests a way that dermatologic artificial intelligence models can be made more generalizable. The presence of background skin was important to the pediatric-specific improvement seen between models. Our study highlights the importance of carefully curated and labeled data from diverse inputs to improve the generalizability of AI models for dermatology, in this case applied to dermoscopic images of adult and pediatric lesions to improve melanoma detection.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interests:
AH is a shareholder of Skip Derm, LLC. AH and has provided services for Janssen, SciBase, Canfield Scientific, and HealthCert International. HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH, and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc, Blaze Bioscience Inc, MoleMap Australia Pty Ltd, Revenio Research Oy and a Medical Advisor for First Derm. VR is an expert consultant for Inhabit Brands, Inc and expert advisor for Inhabit Brands, Inc
Conflicts of Interests:
AH is a shareholder of Skip Derm, LLC. AH has provided services for Janssen, SciBase, Canfield Scientific, and HealthCert International. compensation for provision of services from HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH, and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc, MoleMap Australia Pty Ltd, Revenio Research Oy and a Medical Advisor for First Derm.
Figures




References
-
- Adamson AS, Smith A. Machine Learning and Health Care Disparities in Dermatology. JAMA Dermatol 2018;154(11):1247. - PubMed
-
- Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J. Am. Acad. Dermatol 2013;68(6):913–25 - PubMed
-
- Cruz-Roa A, Caicedo JC, González FA. Visual pattern mining in histology image collections using bag of features. Artif. Intell. Med 2011;52(2):91–106 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical